Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
h Ping An Ins HK SDR2to1 (HPAD.SI)
Shenzhen, GD, CN
Ping An Insurance (Group) Company of China, Ltd. operates as a leading financial services conglomerate within the People's Republic of China, delivering a broad array of financial products and solutions. Its core offerings span life and health insurance, property and casualty coverage, trust services, securities, and banking. The enterprise is structured across five primary segments: Life and Health Insurance, Property and Casualty Insurance, Banking, Asset Management, and Finance Enablement. For both individual and corporate clients, Ping An provides diverse insurance policies, including term, whole-life, endowment, annuity, investment-linked, universal life, and various health and medical insurance options. Its property and casualty portfolio covers automotive, non-automotive, and accident and health insurance. Beyond insurance, the company offers extensive banking and financial services, encompassing loan origination and intermediary activities for corporate and retail customers, alongside wealth management and credit card services tailored for individuals. Its comprehensive financial toolkit further includes trust product administration, brokerage, trading, investment banking, and investment management services, complemented by finance leasing and other asset management operations. Harnessing digital technologies, Ping An also delivers financial and daily-life services via online platforms, specifically its financial transaction information service portal and health care service platform. The company's diverse business ventures extend considerably, involving annuity provision, IT and business process outsourcing, internet services, monetary services, customer loyalty programs, corporate governance, and credit information services. It actively participates in futures and currency brokerage, real estate investment and development, property leasing and management, and operates as both a property and insurance sales agency. Further undertakings include fund raising and distribution, commercial factoring, expressway management, equity investment, securities investment and brokerage, fund sales and settlement, and the manufacturing and sale of consumer chemicals. Additionally, Ping An engages in logistics and warehousing, e-commerce, micro-lending, various consulting services, infant product distribution, real estate consultancy, and commodity trading. This expansive organization was founded in 1988 and is headquartered in Shenzhen, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.65% | -2.18% | -4.27% | -10.69% | +3.79% | -9.04% | +31.12% | +23.25% | +23.25% | +23.25% | +23.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Insurance - Life: +10.6%+14.3% ★ Q2'25: +5.9% (vs Q2'24)
-
EPS growth Insurance - Life: +13.4%+47.5% ★
-
FCF margin FCF growth · Insurance - Life: +31.7%+56.8% Q2'25: +39.7% (vs Q2'24)
-
EBIT margin Insurance - Life: +12.4%+20.7% ★ Q2'25: +25.9% (vs Q2'24)
-
ROIC Insurance - Life: +1.0%+9.3% ★ Q2'25: +12.0% (vs Q2'24)
-
Share dilution Insurance - Life: +0.4%+0.2%
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×6.71× Q2'25: 5.46× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. |
Dec 2027 8 Rev. Ana. |
|---|---|---|---|
| Revenue |
573.34B
est.
|
583.37B
570.71B – 598.80B
+1.7% YoY
|
620.95B
594.02B – 653.60B
+6.4% YoY
|
| EBITDA |
121.13B
est.
|
123.25B
120.57B – 126.51B
+1.7% YoY
|
131.19B
125.50B – 138.09B
+6.4% YoY
|
| EBIT |
109.20B
est.
|
111.11B
108.70B – 114.05B
+1.7% YoY
|
118.27B
113.14B – 124.49B
+6.4% YoY
|
| Net Income |
—
est.
|
—
— – —
|
—
— – —
|
| SGA |
29.14B
est.
|
29.65B
29.00B – 30.43B
+1.7% YoY
|
31.56B
30.19B – 33.21B
+6.4% YoY
|
| EPS |
—
est.
|
—
— – —
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Xiaotao Guo | Co-CEO, Senior VP & Executive Director | 1M | male |
| Xin Fu | Executive Director, Chief Financial Officer & Senior Vice President | 1M | female |
| Yonglin Xie | Co-CEO, President & Executive Director | 809.3K | male |
| Fangfang Cai | Senior VP & Executive Director | 689.3K | female |
| Mingzhe Ma | Founder & Executive Chairman | 676.4K | male |
| Shibang Guo | Assistant President & Chief Risk Officer | — | male |
| Ray Wang | Chief Technology Officer & General Manager | — | male |
| James E. Garner | Chief Strategist & Head of Investor Relations | — | male |
| Jing Xu | Chief Compliance Officer | — | male |
| Baoxin Huang | Senior Vice President | — | male |
| Ruisheng Sheng | Company Secretary & Board Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HPAD.SI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
